Phenobarbital Tablet · 8 active FDA presentation rows for this drug
Brand: PHENOBARBITAL
FDA lists Phenobarbital Tablet as To Be Discontinued (Endo Pharmaceuticals, Inc.).
No availability text on this FDA row.
Phenobarbital Tablet: To Be Discontinued
FDA availability text is not recorded on this row. 8 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Phenobarbital Tablet
- Manufacturer
- Endo Pharmaceuticals, Inc.
- Dosage Form
- Tablet
- Presentation
- Phenobarbital, Tablet, 32.4 mg (NDC 0603-5166-21)
- Package NDC
- 0603-5166-21
Status & Timeline
- Status
- To Be Discontinued
- First Reported
- Oct 31, 2025
- Last Updated
- Oct 31, 2025
- Therapeutic Category
- Analgesia/Addiction, Neurology, Other
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Discontinuation of the manufacture of the drug
Full Drug Profile
phenobarbital
Side effects, interactions, warnings & more
Nearby, Other Phenobarbital Shortage Records
Phenobarbital Tablet
Endo Pharmaceuticals, Inc.
Tablet
Phenobarbital Tablet
Endo Pharmaceuticals, Inc.
Tablet
Phenobarbital Tablet
Endo Pharmaceuticals, Inc.
Tablet
Phenobarbital Tablet
Endo Pharmaceuticals, Inc.
Tablet
Phenobarbital Tablet
Endo Pharmaceuticals, Inc.
Tablet
Phenobarbital Tablet
Endo Pharmaceuticals, Inc.
Tablet
FDA reason on file: Discontinuation of the manufacture of the drug. General shortage guidance lives on the tracker hub.